Ketorolac May Increase Hematoma Risk in Reduction Mammaplasty: A Case-control Study

BACKGROUND: Ketorolac is a potent nonsteroidal anti-inflammatory drug that has valuable analgesic properties but also a hypothetical risk of increased bleeding due to inhibition of platelet activation. The clinical significance of this risk, however, is unclear when it is used after reduction mammap...

Descripción completa

Detalles Bibliográficos
Autores principales: Barkho, Jouseph O., Li, Yu Kit, Duku, Eric, Thoma, Achilleas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5908486/
https://www.ncbi.nlm.nih.gov/pubmed/29707458
http://dx.doi.org/10.1097/GOX.0000000000001699

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5908486/
https://www.ncbi.nlm.nih.gov/pubmed/29707458
http://dx.doi.org/10.1097/GOX.0000000000001699

Ejemplares similares